Pfizer

Markets

Moderna and Pfizer with 5.5% interest and 50% protection – columns

Moderna and Pfizer with 5.5% interest and 50% protection In the case of bonds and certificates whose potential returns depend…

Read More »
Latest

BioNTech and Pfizer: Difficulties in delivering the COVID-19 vaccine looming

BioNTech’s partner Pfizer has apparently admitted that there will be bottlenecks in deliveries of the COVID-19 vaccine in the next…

Read More »
Latest

BioNTech and Pfizer: Next billion dollar deal with US government for COVID-19 vaccine

BioNTech and its sales partner Pfizer will deliver an additional 100 million doses of the COVID-19 vaccine BNT162 to the…

Read More »
Latest

BioNTech and Pfizer have almost reached their goal in the EU too: approval within reach!

BioNTech and Pfizer will shortly be able to announce approval for their vaccine against the pathogen causing COVID-19 in the…

Read More »
Latest

BioNTech and Pfizer: EU approval for COVID-19 vaccine next Wednesday?

Update 12:55 p.m.: According to the AFP news agency, approval of the vaccine before Christmas in Europe is anything but…

Read More »
Latest

BioNTech and Pfizer are US on target – COVID-19 vaccine approved

After the decisions at the most recent crucial meeting of the responsible Fed committee, it was actually just a mere…

Read More »
Markets

Pfizer discounter with 8% chance and 21% discount – columns

Pfizer discounter with 8% chance and 21% discount The shares of the US group Pfizer (ISIN: US7170811035), one of the…

Read More »
Latest

Pfizer: No purchase recommendation for the BioNTech partner

The corona vaccine developed by BioNTech and Pfizer shows, according to the latest reports, an effectiveness of 95 percent. So…

Read More »
Latest

Pfizer: New course target with BioNTech partner

The results of the phase III study by Pfizer and BioNTech for their corona vaccine are well received by the…

Read More »
Markets

Pfizer and Biontech share prices rise

D.he fear of weakening economic stimuli and economic damage from the rampant corona pandemic weighed on the US stock exchanges…

Read More »
Back to top button
Close
Close